Obesity may shorten colon cancer survival

Obesity may shorten colon cancer survival
Patients' risk of death rises with every 5-point increase in BMI, study suggests.

(HealthDay)—Colon cancer patients who were obese before their diagnosis may have an increased risk of dying from their cancer and other causes, a new study finds.

"Our data provide further evidence that maintaining a healthy body weight throughout life is very important," said study author Peter Campbell, director of the tumor repository in the American Cancer Society's epidemiology research program. "They also suggest that prediagnosis BMI may be something that clinicians should consider when managing patient care."

BMI, or , is a measurement of body fat based on height and weight. A BMI of 30 or more is considered obese.

The study included more than 6,700 colon patients whose BMI two years before diagnosis was calculated based on self-reports. The patients were followed for an average of just over five years.

A higher BMI before diagnosis was associated with increased risk of death from colon cancer and all other causes. The association seen in the study does not prove a cause-and-effect relationship.

However, for every 5-point increase in BMI, there was a 7 percent higher risk of death from and a 10 percent higher risk of death from all causes, the researchers said.

An increased risk of death among was seen even in those whose tumors carried an indicator that is typically associated with better results. This indicator is called "microsatellite instability," or MSI. Every 5-point increase in BMI boosted the risk of all-cause death by 19 percent in patients with MSI-high tumors and by 8 percent in those with MSI-stable/MSI-low tumors, the study found.

The study was scheduled for presentation Wednesday at the annual meeting of the American Association for Cancer Research in San Diego.

"Now that we have seen that obesity attenuates the survival advantage observed for patients with MSI-high tumors, we are looking at how it affects other tumor markers that have relevance for colorectal cancer survival," Campbell said in an association news release.

Data and conclusions presented at meetings are typically considered preliminary until published in a peer-reviewed medical journal.

More information: The American Cancer Society has more about colon cancer.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Researcher to cancer: 'Resistance will be futile'

4 hours ago

Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease. "Cancer cells rapidly ...

How does prostate cancer form?

6 hours ago

Prostate cancer affects more than 23,000 men this year in the USA however the individual genes that initiate prostate cancer formation are poorly understood. Finding an enzyme that regulates this process ...

Low risk of malignancy for small complex adnexal masses

13 hours ago

(HealthDay)—For older women with small complex adnexal masses, the overall risk of malignancy is low, according to a study published in the December issue of the American Journal of Obstetrics & Gynecology.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.